Innsbruck University Hospital, Inner Medicine,

Innsbruck A-6020

0 studies enrolling now · 1 studies all time

What they study most

B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Studies at this site

• Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion — Stopped early